| |
|
|
|
AzurRx BioPharma Inc.  
|
|
2.64 -0.03 (-0.01%) |
10-19 16:00 |
|
Open: |
2.63 |
Pre close: |
2.67 |
Target:
|
3.64
|
|
High: |
2.72 |
Low: |
2.56 |
Resistance:
|
3.12
3.75
|
|
Volume: |
109,582 |
Market Cap: |
45M |
Support:
|
2.10
1.75
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.59
 |
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
2.58  |
Signal(12,26,9): |
-0.03 |
|
MA(100): |
2.70 |
Stochastic Oscillator |
%K(14,3):
|
76.26 |
|
MA(250): |
2.90 |
%D(3): |
65.67 |
|
Average Volume(K) |
3-Month: |
9104
|
52-Week |
High:
|
4.08 |
|
10-Days: |
9653 |
Low: |
2.10 |
|
RSI |
RSI(14):
|
53.37 |
Change(%): |
-20.0 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.570 |
Return on Equity (ttm) |
-202.9 |
Shares Out. (M) |
16.91 |
|
EPS Est. Current Year |
-0.850 |
Return on Assets (ttm) |
-121.3 |
Shares Float (M) |
16.10 |
|
EPS Est. Next Year |
-0.670 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.160 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
16.20 |
|
Forward EPS |
-0.640 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
43 |
|
Book Value (p.s.) |
5.210 |
EBITDA (p.s.) |
-0.151 |
P/E |
-4.63 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.51 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-8.62 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-5.23 |
P/CF |
-5.18 |
|
|
|
|
|
|
